Home › Compare › IVMED vs RYLD

IVMED vs RYLD: Dividend Comparison 2026

IVMED yields 285714.29% · RYLD yields 12.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IVMED wins by $1.734986541242196e+31M in total portfolio value
10 years
IVMED
IVMED
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full IVMED calculator →
RYLD
RYLD
● Live price
12.14%
Share price
$14.95
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.5K
Annual income
$2,587.35
Full RYLD calculator →

Portfolio growth — IVMED vs RYLD

📍 IVMED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIVMEDRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IVMED + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IVMED pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVMED
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,031.60/yr
After 10yr DRIP, annual income (after tax)
$2,199.25/yr
At 15% tax rate, IVMED beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVMED + RYLD for your $10,000?

IVMED: 50%RYLD: 50%
100% RYLD50/50100% IVMED
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVMED buys
0
RYLD buys
0
No recent congressional trades found for IVMED or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIVMEDRYLD
Forward yield285714.29% ✓12.14%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.734986541242196e+31M$44.5K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$2,587.35
Total dividends collected$1.734908400352195e+31M$18.8K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: IVMED vs RYLD ($10,000, DRIP)

YearIVMED PortfolioIVMED Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,914$1,213.65+$28.57M → IVMED
2$76,351,353,429$76,320,770,551.21$14,099$1,351.30+$76351.34M → IVMED
3$190,619,493,207,524$190,537,797,259,355.30$16,580$1,494.55+$190619493.19M → IVMED
4$444,781,927,427,195,200$444,577,964,569,463,100.00$19,384$1,642.61+$444781927427.18M → IVMED
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$22,535$1,794.70+$969967353346567.13M → IVMED
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$26,063$1,950.00+$1976961629315092992.00M → IVMED
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$29,995$2,107.69+$3.765923944594039e+21M → IVMED
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$34,361$2,266.99+$6.704681437057683e+24M → IVMED
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$39,194$2,427.12+$1.1156275836497015e+28M → IVMED
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$44,525$2,587.35+$1.734986541242196e+31M → IVMED

IVMED vs RYLD: Complete Analysis 2026

IVMED — Stock

Whitebeard Inc., a development stage company, engages in the research and development of medical devices with `near-patient' testing applications. Its primary product includes prothrombin monitor, which is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke. The company's other products under development include predictor of labor onset, a consumer device for maternity planning; biomarker monitor for the measurement of a number of biomarkers, including heart attack, HIV, cholesterol, and cancer; blood glucose monitor, a noninvasive glucose concentration continuous bulk measuring device measurement; digital scanning machine, a noninvasive alternative to 2D X-ray scanning; osteoporosis detection and monitoring device, an instant display of bonemineral density for osteoporosis patients; and hand held digital strip reader for immunoassay applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. The company is based in Inverness, the United Kingdom.

Full IVMED Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this IVMED vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVMED vs SCHDIVMED vs JEPIIVMED vs OIVMED vs KOIVMED vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.